CDK6 and cancer: Cyclin-dependent kinase 6 (CDK6), a promising target for anti-cancer therapy, is the catalytic subunit of the CDK6-cyclin D complex, which promotes G1/S cell cycle progression and negatively regulates cell differentiation [47].